Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keeps is a telehealth platform primarily focused on men's health, offering subscription-based treatments for hair loss and testosterone replacement therapy (TRT). The company provides access to licensed physicians who evaluate patients and prescribe FDA-approved medications, which are then delivered directly to the consumer. Their TRT service includes lab testing, clinical consultation, and ongoing monitoring to treat symptoms of low testosterone. Keeps operates as a brand under the parent company Thirty Madison, aiming to make specialized healthcare more accessible and affordable. The platform integrates diagnostic testing with long-term care management to improve patient outcomes in chronic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keeps TRT.